HK1188122A1 - 牛蒡子苷元預防或治療骨髓抑制的用途 - Google Patents

牛蒡子苷元預防或治療骨髓抑制的用途

Info

Publication number
HK1188122A1
HK1188122A1 HK14100853.0A HK14100853A HK1188122A1 HK 1188122 A1 HK1188122 A1 HK 1188122A1 HK 14100853 A HK14100853 A HK 14100853A HK 1188122 A1 HK1188122 A1 HK 1188122A1
Authority
HK
Hong Kong
Prior art keywords
arctigenin
preventing
bone marrow
treating bone
marrow suppression
Prior art date
Application number
HK14100853.0A
Other languages
English (en)
Inventor
趙志全
Original Assignee
魯南制藥集團股份有限公司 號
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 魯南制藥集團股份有限公司 號 filed Critical 魯南制藥集團股份有限公司 號
Publication of HK1188122A1 publication Critical patent/HK1188122A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
HK14100853.0A 2010-10-08 2014-01-27 牛蒡子苷元預防或治療骨髓抑制的用途 HK1188122A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010299279.XA CN102440986B (zh) 2010-10-08 2010-10-08 牛蒡子苷元在制备防治辐射或化学品引起的骨髓抑制的药物中的用途
PCT/CN2011/080543 WO2012045282A1 (zh) 2010-10-08 2011-10-08 牛蒡子苷元在制备预防或治疗血细胞减少相关疾病的药物中的用途

Publications (1)

Publication Number Publication Date
HK1188122A1 true HK1188122A1 (zh) 2014-04-25

Family

ID=45927226

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14100853.0A HK1188122A1 (zh) 2010-10-08 2014-01-27 牛蒡子苷元預防或治療骨髓抑制的用途

Country Status (8)

Country Link
US (1) US20130190394A1 (zh)
EP (1) EP2626071B1 (zh)
JP (1) JP5744213B2 (zh)
KR (1) KR101512495B1 (zh)
CN (2) CN102440986B (zh)
AU (1) AU2011313667B2 (zh)
HK (1) HK1188122A1 (zh)
WO (1) WO2012045282A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102397547B (zh) * 2010-09-19 2013-06-12 山东新时代药业有限公司 一种抗癌药物组合物
CN102440986B (zh) * 2010-10-08 2014-12-03 鲁南制药集团股份有限公司 牛蒡子苷元在制备防治辐射或化学品引起的骨髓抑制的药物中的用途
CN103027906B (zh) * 2011-10-08 2015-11-11 鲁南制药集团股份有限公司 牛蒡子苷元在治疗贫血疾病中的应用
CN104379143A (zh) * 2012-03-26 2015-02-25 客乐谐制药株式会社 抗癌剂
CN103446100A (zh) * 2012-05-29 2013-12-18 鲁南制药集团股份有限公司 牛蒡子苷元的舌下含服制剂
JP5696191B2 (ja) * 2013-04-27 2015-04-08 クラシエ製薬株式会社 抗癌幹細胞剤
KR101891505B1 (ko) 2013-10-21 2018-08-24 루난 파마슈티컬 그룹 코퍼레이션 혈구 감소를 예방 또는 치료하기 위한 약물의 제조에 있어서의 안히드로이카리틴의 용도
CN104546823B (zh) * 2013-10-21 2019-08-30 鲁南制药集团股份有限公司 淫羊藿苷元在制备治疗或预防血小板减少症药物中的用途
JP6234553B2 (ja) * 2014-04-10 2017-11-22 クラシエ製薬株式会社 抗癌剤および副作用軽減剤
JP6197077B1 (ja) * 2016-07-14 2017-09-13 クラシエ製薬株式会社 抗癌剤、放射線増感剤および食品組成物
CN110623960B (zh) * 2018-06-22 2022-08-19 成都山权江生物科技有限公司 一种小分子化合物在制备治疗阿尔茨海默病的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148955A1 (en) * 1999-04-19 2003-08-07 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
CN1243103C (zh) * 2004-02-26 2006-02-22 广州中医药大学 一种制备抗病毒与抗肿瘤天然药物牛蒡子苷元的方法
EP1984377A2 (en) * 2006-01-17 2008-10-29 Signal Pharmaceuticals LLC Inhibitors of tnf alpha , pde4 and b-raf, compositions thereof and methods of use therewith
CN101036643A (zh) * 2006-03-13 2007-09-19 海南盛科天然药物研究院有限公司 含牛蒡子苷元的药物组合物及其制备方法
CN101134031B (zh) 2006-08-30 2012-05-09 山东绿叶天然药物研究开发有限公司 牛蒡子苷元在制备治疗或预防慢性肾功能衰竭及肾纤维化的药物中的用途
WO2011120339A1 (zh) * 2010-04-03 2011-10-06 鲁南制药集团股份有限公司 牛蒡苷元的微乳制剂
CN102440986B (zh) * 2010-10-08 2014-12-03 鲁南制药集团股份有限公司 牛蒡子苷元在制备防治辐射或化学品引起的骨髓抑制的药物中的用途

Also Published As

Publication number Publication date
JP5744213B2 (ja) 2015-07-08
JP2013542205A (ja) 2013-11-21
EP2626071A1 (en) 2013-08-14
KR20130093125A (ko) 2013-08-21
CN103209693A (zh) 2013-07-17
CN102440986A (zh) 2012-05-09
AU2011313667A1 (en) 2013-05-02
EP2626071A4 (en) 2014-04-02
KR101512495B1 (ko) 2015-04-15
CN102440986B (zh) 2014-12-03
AU2011313667B2 (en) 2015-08-27
WO2012045282A1 (zh) 2012-04-12
CN103209693B (zh) 2015-10-07
EP2626071B1 (en) 2016-01-13
US20130190394A1 (en) 2013-07-25

Similar Documents

Publication Publication Date Title
HK1188122A1 (zh) 牛蒡子苷元預防或治療骨髓抑制的用途
HK1221917A1 (zh) 用於治療退化骨病症的方法
HK1214525A1 (zh) 激活素- 拮抗劑和用於治療骨和其它病症的用途
EP2608778A4 (en) COMPOSITIONS AND METHODS FOR TREATING BONE ANOMALIES
HK1205005A1 (zh) 骨治療系統
ZA201302625B (en) Methods and compositions for treating hemophilia b
EP2555760A4 (en) METHODS AND COMPOSITIONS FOR TREATING INJURIES USING CHITOSAN COMPOUNDS
EP2629736A4 (en) FABRIC TREATMENT
EP2542060A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES
EP2396019A4 (en) METHOD AND COMPOSITIONS FOR SKIN TREATMENT
EP2538988A4 (en) METHOD FOR TISSUE-DECELULARIZATION
IL225924A (en) Dlbcl treatment
EP2544655A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN
GB2478797B (en) Waste treatment
ZA201208413B (en) Skin treatment composition
ZA201303423B (en) Compositions and methods for treating myelofibrosis
SG10201500124VA (en) Methods and Compositions for Treating Cancer
GB2497899B (en) Sanguiin for use in the prevention or treatment of bone marrow inhibition
EP2575825A4 (en) COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
GB201002083D0 (en) Apparatus for improving and/or maintaining numerical ability
HK1183766A1 (zh) 用於治療瘀傷的組合物和方法
EP2542057A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFAMOUS DISEASES
EP2534302A4 (en) SURFACE TREATMENT COMPOSITION
IL225483A0 (en) The compositions and methods for the treatment of neoplasia